Beacon Transcript

Information which Matters to You

Tuesday, September 21, 2021
Log in

SciClone Pharmaceuticals Climbs To Near 15-Year High

By

SciClone Pharmaceuticals shares rose to their highest level since 2000 in mid-morning trade Thursday after the specialty pharmaceutical company reported better-than-expected Q4 results late Wednesday. Shares were most recently higher 17%, down from the earlier high of $9.65. The 52-week low is at $4.24.

The company said Q4 sales were $41.4 million, more than the Cap IQ estimate for $38.93 million. Non-GAAP EPS rose to $0.29 from $0.07 a year ago and beat estimates for $0.16.

Reported earnings rose to $3.5 million or $0.07 per diluted share from $36,000 or $0.00 per share a year earlier.

It sees FY15 sales between $153 million and $158 million, driven by ZADAXIN revenues, and non-GAAP EPS between $0.73 and $0.77. Analysts are looking for revenue of $155 million and EPS of $0.61.

Rosetta Stone Tumbles 11% on Q4 Sales Miss

By

Rosetta Stone is trading more than 11% lower on Thursday, just shy of its 52-week low of $7.42 after reporting disappointing Q4 results after the close on Wednesday.

RST Q4 sales were $79.2 million, below the Capital IQ estimate for $81.33 million. Net loss per share widened to $1.01 from a loss of $0.18 a year ago. Estimates, usually less items, were for a $0.09 loss.

It says it is refocusing its corporate strategy and realigning resources around its Global E&E segment. This will include cutting global non-E&E headcount approximately 15%, resulting in annual expense reductions of approximately $50 million. These actions will result in an estimated $7 million charge in Q115. It also recorded a non-cash charge of $18.0 million in Q414 to impair the carrying value of goodwill associated with the NA Consumer segment. Shares of RST were last trading at $8.44 with a 52-week range of $7.42 to $12.32.

United Technologies to Explore Strategic Options

By

Shares of United Technologies Corp. climbed nearly 2% Thursday morning after the aerospace and defense company said late Wednesday it will review strategic alternatives for its Sikorsky aircraft business, including a possible spin off.

President and CEO Gregory Hayes said the company is considering whether a spin off of the unit “would allow United Technologies to better focus on providing high-technology systems and services to the aerospace and building industries.”

The strategic review should be concluded before the end of the year, UTX said, noting that a specific timetable has not been set and that a spin off or other transaction is not guaranteed.

UTX will discuss its plan to review strategic alternatives on the maker of Black Hawk and other helicopters at its annual investor meeting at 1:00 p.m. ET on Thursday.

The unit generated approximately $7.5 billion of UTX’s total sales of $65 billion in 2014, the Associated Press noted.

UTX was up 1.8% at $120.44 in recent morning trade, moving near the top end of the 52-week range of $97.30 to $124.45.

Targa Resources Slips

By

Targa Resources shares slipped Thursday after the limited partnership with a portfolio of midstream-energy assets priced an underwritten public offering of nearly 3.3 million shares of its common stock at $91.00 per share, a 3.6% discount to the stock’s Wednesday closing price, for expected net proceeds of about $292.3 million.

TRGP was down 2% at $92.50 recently, in a 52-week range of $82.09 to $160.97. The Company granted the underwriter a 30-day option to purchase up to an additional 487,500 shares of common stock. If the option is exercised in full, net proceeds would be about $336.2 million.

The offering is expected to close on or about March 17. The company intends to use the net proceeds to repay a portion of the outstanding borrowings under its credit facility, to make a capital contribution of approximately $53.0 million to Targa Resources Partners LP, to maintain its 2% general partnership interest in the partnership, and for general corporate purposes.

Cannabis Kinetics Corp. to Launch Re-Branded Monarch America Social Media Strategy

By

Cannabis Kinetics Corp. (“Cannabis Kinetics” or the “Company”) (pending name change to Monarch America Inc.) is pleased to announce the Company’s plan to launch its re-branded social media presence and strategy.

“Re-branding our established social media presence as Monarch America and implementing an effective pro-active social media strategy will be an important factor to our success going-forward as we communicate our new expanded multifaceted business model, particularly outside the marijuana sector,” stated Eric Hagen, CEO of the Company.  “This integrated social media strategy will engage with our current and potential customers, partners, retailers, distributors, and the investment community to build and maintain a positive image of Monarch America as we launch new exclusive consumer products and brands, potentially expand into new markets across the country, and identify further possible partnerships and targeted acquisitions.”

Hagen concluded, “Our social media friends and followers have the opportunity to receive the latest company news, discuss Monarch America brand products and services, view exclusive photos and videos, and connect with important new product launch information.  We are confident that this coordinated social media strategy will help to build awareness for Monarch America and support the Company’s mission to become an innovative corporate and community leader.”

The Company anticipates providing new website and social media links through its current website www.CannabisKinetics.com over the next 72 hours and in subsequent press releases.

Cannabis Kinetics Corp. (pending name change to Monarch America Inc.) files reports with the Securities & Exchange Commission on EDGAR and anticipates continuing to file such reports.  The Company’s filings can be viewed at www.sec.gov.

Categories